We are live on
!
Find out more
NPPM
North Point Portfolio Managers Portfolio holdings
AUM
$561M
1-Year Est. Return
15.77%
This Fund
S&P 500
This Quarter
Est. Return
+8.09%
1 Year Est. Return
+15.77%
3 Year Est. Return
+55%
5 Year Est. Return
+69.33%
10 Year Est. Return
+287.56%
AUM
$588M
AUM Growth
+$33.9M
(+6.1%)
Cap. Flow
-$4.84M
Cap. Flow
% of AUM
-0.82%
Top 10 Holdings %
Top 10 Hldgs %
36.55%
Holding
73
New
5
Increased
10
Reduced
35
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chemed
CHE
|
+$11.6M |
| 2 |
Zebra Technologies
ZBRA
|
+$11.4M |
| 3 |
Apple
AAPL
|
+$495K |
| 4 |
Arthur J. Gallagher & Co
AJG
|
+$494K |
| 5 |
Corning
GLW
|
+$226K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$6.73M |
| 2 |
ANSS
Ansys
ANSS
|
+$5.36M |
| 3 |
Littelfuse
LFUS
|
+$4.63M |
| 4 |
Danaher
DHR
|
+$3.76M |
| 5 |
ExxonMobil
XOM
|
+$3.71M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.98% |
| 2 | Healthcare | 17.84% |
| 3 | Consumer Discretionary | 14.49% |
| 4 | Financials | 14.34% |
| 5 | Consumer Staples | 11.82% |
Similar funds
MCM
FGAM
AC
PDL
GWAG
AMCA
OPWM
HA
North Point Portfolio Managers's Q3 2020 Portfolio in Review
As of Q3 2020, North Point Portfolio Managers held 73 positions worth $588M, up 6.1% from $554M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
North Point Portfolio Managers's Q3 2020 filing shows 5 new, 10 increased, 35 reduced and 5 closed positions. Its largest new stake was Chemed: 23,624 shares worth $11.3M. The largest sale was Regeneron Pharmaceuticals, an estimated $6.73M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- North Point Portfolio Managers's largest Q3 2020 buy was Chemed: 23,624 shares worth $11.3M.
- North Point Portfolio Managers added most to Arthur J. Gallagher & Co in Q3 2020, an estimated $494K increase.
- North Point Portfolio Managers's biggest Q3 2020 reduction was Regeneron Pharmaceuticals, cutting an estimated $6.73M.
- North Point Portfolio Managers fully exited Littelfuse in Q3 2020, selling an estimated $4.63M.
- North Point Portfolio Managers's ten largest holdings make up 37% of its $588M portfolio in Q3 2020.
- North Point Portfolio Managers opened 5 new positions and closed 5 in Q3 2020.
- North Point Portfolio Managers's portfolio value rose 6.1% quarter-over-quarter to $588M.
Based on North Point Portfolio Managers's 13F filing for Q3 2020, filed 27 Oct 2020.